Abbott inks India plan
LIBERTYVILLE TOWNSHIP - Abbott announced it completed its acquisition of Piramal's Healthcare Solutions business, propelling it to market leadership in the Indian pharmaceutical market.
Throughout the past decade, Abbott has established a leading presence in emerging markets.
India's rapid pharmaceutical market growth is being driven largely by branded generics.
The market will generate nearly $8 billion in pharmaceutical sales this year.
Article Comments
Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked.
If a comment violates these standards or our terms of service, click the "flag" link in the lower-right corner of the comment box. To find our more, read our FAQ.